| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1770121/0001480212-26-000004.txt","as_of":"2026-04-09T03:12:49.786272+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1770121/0001480212-26-000004.txt","company":"Sana Biotechnology, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1770121/0001480212-26-000004.txt","article_chars":1518,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_d4df86b9f0e2a627","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1770121/0001480212-26-000004.txt","content_type":"text/plain","enriched_at":"2026-04-09T18:34:31.095221+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1770121/0001480212-26-000004.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1770121/0001480212-26-000004.txt","source_event_id":"evt_84ab30b09402","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"120a4ae680a222b9","kind":"sec_filing","published_at":"20260408","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.72,"dates_mentioned":["2026-04-06","2026-04-08","2026-04-09"],"entities":[{"asset_class":"equity","name":"Sana Biotechnology, Inc.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"equity","name":"Hans Edgar Bishop","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"legal","name":"Aaron M. Grossman","relevance":"medium","symbol":"","type":"signatory"}],"event_type":"listing","information_gaps":["The specific transaction type (e.g., purchase/sale/transfer) is not explicitly stated in the provided cleaned text.","The meaning of the numeric fields (e.g., 7763.00, 0.00, 5848503.00) is not described in the provided excerpt.","No prior known state or comparison delta details are included beyond the fact that this Form 4 was filed; what changed vs prior state is not provided.","No ticker symbol for Sana Biotechnology, Inc. is included in the provided text."],"key_facts":["SEC accession number: 0001480212-26-000004.","Conformed submission type: Form 4.","Conformed period of report: 20260406; filed as of date: 20260408; date as of change: 20260408.","Reporting owner: Hans Edgar Bishop.","Issuer: Sana Biotechnology, Inc. (CIK 0001770121).","Standard industrial classification (SIC): Biological Products (No Diagnostic Substances) [2836].","The filing states: \u201cConsists of fully vested restricted stock units.\u201d","The document is signed: \u201c/s/ Aaron M. Grossman, Attorney-in-Fact for Hans Edgar Bishop.\u201d"],"numeric_claims":[{"label":"Reported common stock amount (as shown)","value":"7763.00"},{"label":"Other numeric field shown as 0.00","value":"0.00"},{"label":"Another numeric field shown as 5848503.00","value":"5848503.00"}],"primary_claim":"Form 4 for Sana Biotechnology, Inc. was filed on 2026-04-08 (covering period 2026-04-06) by reporting owner Hans Edgar Bishop, with the reported common stock consisting of fully vested restricted stock units.","relevance_score":0.45,"sentiment":"neutral","source_quality":"medium","summary":"Sana Biotechnology, Inc. filed a Form 4 on 2026-04-08 reporting a transaction by reporting owner Hans Edgar Bishop. The filing indicates the reported securities are fully vested restricted stock units (RSUs).","topics":["SEC Form 4","insider transaction","restricted stock units","common stock"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Sana Biotechnology, Inc. \u00b7 Filed 20260408","ticker":"SANA","tickers":["SANA"],"title":"SANA filed 4","url":"https://www.sec.gov/Archives/edgar/data/1770121/0001480212-26-000004.txt"}... |